Kinetic Biomarkers of Joint Space Molecules in OA

Information

  • Research Project
  • 6808983
  • ApplicationId
    6808983
  • Core Project Number
    R21AG024120
  • Full Project Number
    1R21AG024120-01
  • Serial Number
    24120
  • FOA Number
    PA-03-67
  • Sub Project Id
  • Project Start Date
    9/30/2004 - 19 years ago
  • Project End Date
    6/30/2006 - 18 years ago
  • Program Officer Name
    TYREE, BERNADETTE
  • Budget Start Date
    9/30/2004 - 19 years ago
  • Budget End Date
    6/30/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/22/2004 - 19 years ago
Organizations

Kinetic Biomarkers of Joint Space Molecules in OA

DESCRIPTION (provided by applicant): Aging results in changes in the composition and function of articular cartilage. The focus of this research is to characterize changes in turnover (synthesis and degredation) of components of hyaline articular cartilage matrix and synovial fluid with age and osteoarthritis (OA). In the finial analysis, it is an imbalance in the regulation of matrix synthesis and/or degradation that results in the loss of articular cartilage and leads to OA (1-4). The general objective of this project it to develop and validate kinetic assays (kinetic biomarkers) of turnover rates of articular cartilage and synovial fluid glycosaminoglycans (GAG), collagen, or collagen derived peptides and chondrocytes in vivo in rodents for ultimate use in drug development, clinical trials and patient care in OA. Specifically, our objectives are (1) to evaluate a newly developed stable isotope/ mass spectrometric method for measuring articular cartilage and synovial fluid turnover rates of the GAG's hyalurenic acid (HA) and chrondroitin-sulfate (CS) in rats and in an animal model of OA (aging guinea pigs). (2) to evaluate a newly developed stable isotope / mass spectrometric method for measuring turnover rates of articular cartilage collagen and synovial fluid collagen-derived peptides in rats and an animal model of OA (aging guinea pigs). (3) to evaluate changes in chrondrocyte cell proliferation with age and OA in the rat and guinea pig. (4) to compare kinetic measurements of these joint protective biochemical constituents (GAG's collagen and its breakdown products, chondrocytes) from different sampling sites (articular cartilage, synovial fluid plasma) in order to understand and interpret changes in these kinetic biomarkers. (5) To compare kinetic measures of these joint protective constituents to histological and static biochemical markers of OA in the guinea pig model. In summary, we propose to develop and test kinetic biomarkers of the major protective compoments of the joint space (GAG's, collagen and chrondrocytes) and to correlate these measures with histologic markers of OA. These tools may allow significant advances in our basic understanding of the biology of the extracellular matrix in the joint space, with potential application to the prevention and treatment of arthritic disorders.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R21
  • Administering IC
    AG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    177188
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
    NIA:177188\
  • Funding Mechanism
  • Study Section
    SBSR
  • Study Section Name
    Skeletal Biology Structure and Regeneration Study Section
  • Organization Name
    KINEMED, INC.
  • Organization Department
  • Organization DUNS
    067568266
  • Organization City
    EMERYVILLE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94608
  • Organization District
    UNITED STATES